Skip to content

Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)

Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) for Measuring Energy Expenditure at Rest and in Dynamic Phase After a Meal in Adult Healthy and Obese Volunteers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00848471
Acronym
Protocol Quark
Enrollment
30
Registered
2009-02-20
Start date
2009-01-31
Completion date
2009-12-31
Last updated
2009-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Obesity

Keywords

Indirect calorimeter, Validation, Energy expenditure, Healthy volunteers

Brief summary

Measurement of energy expenditure at rest (12 hours fasting) and in dynamic phase after a meal (600kcal) to compare the results of the two calorimeters in standardized conditions for the validation of quark RMR versus Deltatrac II

Detailed description

Clinically, energy expenditure is usually estimated using predictive equations, such as the Harris-Benedict equation, which consider the patient's weight, height, age and sex to determine energy needs. However these have been shown to be unsystematically incorrect and may vary by 70-140% when compared with indirect and direct calorimetry measurements. That is why the most popular method of measurement of energy expenditure in research is via indirect calorimetry using a metabolic cart. Indirect calorimetry is the measurement of the volume of oxygen consumption and carbon dioxide production. Actually, there are few numbers of indirect calorimeters available commercialy. The Deltatrac II metabolic cart was the gold standard. It has been extensively used in clinical research both for resting metabolic rate and substrate oxidation measurement during postprandial or an insulin clamp. The Quark RMR is also a metabolic cart too which was launched on the market to compete with the others calorimeters measuring resting metabolic rate. As the Quark RMR and Deltatrac II use the same measure device (paramagnetic analyser for oxygen detection, infrared absorption for carbon dioxide detection) with the same sensitivity and time response according to constructor's data, we want to compare these two calorimeters for the measurement of energy expenditure and substrate oxidation at rest and during a meal in standardized conditions.

Interventions

DEVICEQuark RMR

Quark RMR calorimeter (Cosmed)

DEVICEDeltatrac II

Deltatrac II (GE health Care Clinical Systems)

Sponsors

Centre de Recherche en Nutrition Humaine Rhone-Alpe
CollaboratorOTHER
Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 to 60 years old * BMI between 20 and 35 kg/m² * Weight stable for at least 2 months * Safety subject during medical consultation * Normal TSH -CRP -glycemia - creatinin

Exclusion criteria

* Medical or surgical history which may affect energy expenditure (renal -cardiovascular -hepatic- endocrine-inflamatory diseases) * Drug use that could affect energy expenditure (steroids, nicotine substitutes, thyroid hormones) * Eating disorder * Intensive sportive activity (Baecke's score \>5) * Subjects who Smoke * Claustrophobic subjects * Pregnant women

Design outcomes

Primary

MeasureTime frame
To compare the results obtained for the Deltatrac II and the Quark RMR for the measure of energy expenditure at rest in standardized conditionsAt the end of the study

Secondary

MeasureTime frame
To compare the results obtained for the Deltatrac II and the Quark RMR for the measure of energy expenditure after a food intake of 600kcalAt the end of the study

Countries

France

Contacts

Primary ContactSecretary, Centre de Recherche en Nutrition Rhône Alpes
secretariat.crnh@chu-lyon.fr04.72.11.07.08

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026